NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

TRYPTAMINE THERAPEUTICS LTD (TYP)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 FROMTO
TRYPTAMINE THERAPEUTICS LTD29/05/2024
EXOPHARM LIMITED29/05/2024

Shareholder links

Our website ranking of TYP: rating 2
(2 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Registry Pty Ltd
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000331993
Address: Suite 201, 697 Burke Road Camberwell Victoria 3124
Tel:  03 9092 0475

Date first listed: 18/12/2018

Sector: Pharmaceuticals Biotechnology & Life Sciences 
Activities: Biopharmaceutical research with a primary focus on developing and commercialising exosomes as therapeutic agents

News & Events

Expand this box to read and print

The suspension of trading in the securities of Tryptamine Therapeutics Ltd "“ Formerly Exopharm Ltd will be lifted from the commencement of trading on Wednesday, 29 May 2024 following its re-compliance with Chapters 1 and 2 of the ASX Listing Rules.

29/05/2024

name changed from Exopharm Ltd

29/05/2024

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    02/10/2024Jason Carroll550,000$0.018$9,900
    14/06/2024Jason Carroll604,738$0.020$11,992
    06/06/2024Jason Carroll1,692,514$0.021$36,084
    05/06/2024Jason Carroll952,748$0.022$20,960
    03/06/2024Jason Carroll1,000,000$0.025$25,000

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Jason CarrollCEO01/10/2023
    Hamish GeorgeCFO01/09/2024
    Mark DaviesIndependent Director, Chairman22/06/2023
    Daniel TillettNon Exec Director08/11/2024
    David FranksCompany Secretary

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Peter MolloyNon Exec Director01/05/202408/11/2024
    Clarke BarlowNon Exec Director22/02/202308/11/2024
    Ian DixonManaging Director17/05/201301/05/2024
    Jason WatsonNon Exec Director12/08/201822/06/2023
    Jenn KingIndependent Director01/09/202122/02/2023
    Elizabeth McGregorNon Exec Director05/01/202120/12/2022
    David ParkerNon Exec Director18/12/201805/01/2021

    Date of first appointment, title may have changed.